Irbesartan attenuates Ang II-induced BMP-2 expression in human umbilical vein endothelial cells

Vascular Medicine

Volumn 13, Issue 3, 2008, Pages 239-245

  Zhang, Ming ^a   Zhou, Sheng Hua ^a   Zhao, Shui Ping ^a   Liu, Qi Ming ^a   Li, Xu Ping ^a   Shen, Xiang Qian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Ang II; BMP 2; HUVECs; Irbesartan

Indexed keywords

ANGIOTENSIN II; BONE MORPHOGENETIC PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRBESARTAN; MALONALDEHYDE; PYRROLIDINE DITHIOCARBAMATE; SUPEROXIDE DISMUTASE; ANGIOTENSIN RECEPTOR ANTAGONIST; BIPHENYL DERIVATIVE; BMP2 PROTEIN, HUMAN; TETRAZOLE DERIVATIVE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; CULTURE MEDIA; DRUG INTERACTIONS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; MALONDIALDEHYDE; SUPEROXIDE DISMUTASE; TETRAZOLES; TRANSCRIPTION FACTOR RELA; UMBILICAL VEINS; VASOCONSTRICTOR AGENTS;

EID: 58149386378     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X08089282     Document Type: Article

References (29)

1. Abedin M, Tintut Y, Demer LL. Vascular calcification: Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24: 1161-1170.
2. Csiszar A, Smith KE, Koller A, et al. Regulation of bone morphogenetic protein-2 expression in endothelial cells: Role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 2005; 111: 2364-2372.
3. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006; 99: 1044-1059.
4. Shanahan CM, Cary NR, Metcalfe JC, et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994; 93: 2393-2402.
5. Demer L, Watson KE, Bostrom K. Mechanism of calcification in atherosclerosis. Circulation 2005; 111: 2364-2372.
6. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005; 97: 105-114.
7. Parhami F, Bostrom K, Watson K, et al. Role of molecular regulation in vascular calcification. J Atheroscler Thromb 1996; 3: 90-94.
8. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
9. Kranzhofer R, Schmidt J, Pfeiffer CA, et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1623- 1629.
10. Tummala PE, Chen XL, Sundell CL. et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999; 100: 1223-1229.
11. Morawietz H, Erbs S, Holtz J, et al. Endothelial protection, AT1 blockade and cholesterol-dependent oxidative stress: The EPAS trial. Circulation 2006; 114(Suppl.1):I296-I330.
12. Hernandez-Presa M, Bustos C, Ortego M, et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95: 1532-1541.
13. Zhang WJ, Wojta J, Binder BR. Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo. Arterioscler Thromb Vasc Biol 1997; 17: 465-474.
14. Kapoor R, Prasad K. Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion: Effect of SOD and catalase. Circ Shock 1994; 43: 79-94.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
16. Fukai T, Galis Z, Meng XP, et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest 1998; 101: 2101-2111.
17. Assem M, Teyssier J-R, Benderitter M. Pattern of superoxide dismutase enzymatic activity and RNA changes in rat heart ventricles after myocardial infarction. Am J Pathol 1997; 151: 549-555.
18. Lowry O, Rosebrough N, Farr A, et al. Protein measurement with the folin-phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Oyama VI, Eagle H. Measurement of cell growth in tissue culture with a phenol reagent (Folin-Ciocalteau). Proc Soc Exp Biol Med 1956; 91:305-307.
20. Zhang H, Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996; 122: 2977-2986.
21. Suzuki Y, Ruiz-Ortega M, Lorenzo O, et al. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881-900.
22. Ferrario, CM, Strawn, WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121-128.
23. Hernan dez-Presa, M, Bustos, C, Ortego, M, et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95: 1532-1541.
24. Tsikouris JP, Cox CD. Pharmacologic blockade of the renin-angiotensin system: Vascular benefits beyond commonly understood pharmacologic actions. Pharmacotherapy 2003; 23: 1141-1152.
25. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20: 645-651.
26. Nowicki PT, Flavahan S, Hassanain H, et al. Redox signaling of the arteriolar myogenic response. Circ Res 2001; 89: 114-116.
27. Sawayama Y, Shimizu C, Maeda N, et al. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia: Fukuoka Atherosclerosis Trial (FAST). J Am Coll Cardiol 2002; 39: 610-616.
28. Mackness B, Durrington PN, Mackness MI. Lack of protection against oxidative modification of LDL by avian HDL. Biochem Biophys Res Commun 1998; 247: 443-446.
29. Traverso N, Menini S, Maineri EP, et al. Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins. J Gerontol A Biol Sci Med Sci 2004; 59: B890-B895.